Hepatic encephalopathy: A neurochemical, neuroanatomical and neuropsychological study

Journal of Applied Clinical Medical Physics

Volumn 7, Issue 1, 2006, Pages 86-96

  Binesh, Nader ^a   Huda, Amir ^a,b   Thomas, M Albert ^a,c   Wyckoff, Nathaniel ^a   Bugbee, Mary ^a   Han, Steven ^c   Rasgon, Natalie ^c   Davanzo, Pablo ^c   Sayre, James ^a   Guze, Barry ^c   Martin, Paul ^c   Fawzy, Fawzy ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral metabolites; Choline; Glutamine glutamate; Hyperintensity; Myo inositol; Neuropsychology; PRESS

Indexed keywords

BIOLOGICAL MARKER; NERVE PROTEIN;

ADULT; AGED; ARTICLE; BRAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PSYCHOLOGICAL ASPECT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; TISSUE DISTRIBUTION;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; TISSUE DISTRIBUTION;

EID: 33645388889     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.2027.25374     Document Type: Article

References (36)

1. Gitlin N. Hepatic encephalopathy. In: Zorkin D, Boyer TD, editors. Hepatology. Philadelphia (PA): Saunders; 1996: 605-617.
2. Bernthal P, Hayes A, Tarter RE, Van Thiel D, Lecky J, Hegedus A. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 1987;7:107-114.
3. Blei AT, Cordoba J. Subclinical encephalopathy. Digest Dis. 1996;14:2-11.
4. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CTW. Multisection proton MR spectrosocopic imaging of the brain. Radiology 1993;188:277-282.
5. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT, and the Members of the Working Party. Hepatic encephalopathy - Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721.
6. Chalasani N, Gitlin N. Subclinical hepatic encephalopathy: How best to diagnose? Am J Gastroent. 1997;92(5):905-906.
7. Butterworth RF. Hepatic encephalopathy. Neurologist 1995;1:95-104.
8. Fraser CL, Arieff AI. Hepatic encephatopathy. New Eng J Med. 1995;313:865.
9. Ross BD, Danielsen ER, Bluml S. Proton magnetic resonance spectroscopy: The new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Digest Dis. 1996;14(Suppl 1):30-39.
10. Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: An MR imaging study. Mag Res Imag. 1991;9:295-302.
11. Kulisevsky J, Pujol J, Balanzo J, et al. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: Clinical correlations. Hepatology 1992;16:1382-1388.
12. Inoue E, Hori S, Narumi Y, et al. Portal-systemic encephalopathy: Presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991;179:551-555.
13. 1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metabol Brain Dis. 1995;10(2):175-188.
14. Layrargues GP, Shapcott D, Spahr L, Butterworth RF. Accumulation of manganese and copper in pallidum of cirrhotic patients: Role in the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 1995;10:353-356.
15. Hauser RA, Zesiewicz TA, Martinez C, Rosemurgy AS, Olanow CW. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci. 1996;23:95-98.
16. Layrargues GP, Rose C, Spahr L, Zayed J, Normandin L, Butterworth RF. Role of manganese in the pathogenesis of portal-systemic encephalopathy. Metab Brain Dis. 1998;13:311-317.
17. 1H MRS in patients with chronic hepatic encephalopathy - Regional variations. Book of abstracts. Society of Magnetic Resonance; 1994;571.
18. Huda A, Thomas MA, Bugbee M, et al. Regional variations of metabolites in hepatic encephalopathy. Book of abstracts. Society of Magnetic Resonance; 1995: 1838.
19. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities. Radiology 1994;193:457-63.
20. 1H MR spectroscopy and neuropsychological status of patients with hepatic encephalopathy. AJR 1998;171:1123-1130.
21. 1H MR spectroscopy in hepatic encephalopathy. Psychosom Med 1998;60:550-556.
22. 1H MR spectroscopy. Radiology 1992;182:9-27.
23. Bottomley PA. Proton MR spectroscopy for diagnosing hepatic encephalopathy? Radiology 1992;182:6-7.
24. 1H MR spectroscopy. Glutamate and glutsmine; Myo-inositol and related metabolites. NMR Biomed. 1991;4:59-63.
25. Geissler G, Lock R, Frund R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997;25:48-54.
26. Jalan R, Shawcross D, Davies N. The molecular pathogenesis of hepatic encephalopathy. Int J Biocbem Cell Biol. 2003;35:1175-1181.
27. Glickson JD. Clinical NMR spectroscopy of tumors: Current status and future directions. Invest Radiol. 1989;24:1011-1016.
28. Daly PF, Cohen JS. MR spectroscopy of tumors and potential in vivo clinical applications: A review. Cancer Res. 1989;49:770-779.
29. Fountas KN, Kapsalaki EZ, Gotsis SD, et al. In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg. 2000;74:83-94.
30. Boddie AW, Frazer JW, Tomasovic SP, Dennis L. Application of MR spectroscopy to the study of tumor biology. J Surg Res. 1989;46:90-97.
31. Brown MS, McNitt-Gray MF, Wyckoff N, Bui A. An object-oriented region of interest toolkit for workstations. In: Kim Y, editor. Medical Imaging 1998: Image Display, Proc SPIE 1998;3335:627-636.
32. Provencher SW. Estimation of metabolites concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672-679.
33. Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995.
34. Larzelere RE, Mulak SA. Single-sample tests for many correlations. Psychol Bull. 1977;84:557-569.
35. 1HMRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy. Metabol Brain Dis. 2002;17:399-413.
36. Thomas MA, Yue K, Binesh N, et al. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magn Reson Med 2001;46:58-67.